TNDM | tickerfilter.com

Fundamental analysis

41%

Profitability 25%

Dept financing 50%

Liquidity 40%

Performance 55%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

5.72%

1 Month

-15.34%

3 Months

2.41%

6 Months

38.01%

1 Year

29.59%

2 Year

-33.06%

Key data

Stock price

$21.24

P/E Ratio

0.00

DAY RANGE

$20.78 - $21.86

EPS

-$3.04

52 WEEK RANGE

$9.98 - $29.65

52 WEEK CHANGE

$29.91

MARKET CAP

1.490 B

YIELD

N/A

SHARES OUTSTANDING

68.326 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

07-31-2025

BETA

1.52

PUBLIC FLOAT

AVERAGE 10 VOLUME

$1,653,484

AVERAGE 30 VOLUME

$1,671,123

Company detail

CEO: John F. Sheridan
Region: US
Website: tandemdiabetes.com
Employees: 2,600
IPO year: 2007

Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Tandem Diabetes Care, Inc. designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system. It also offers t:connect, a web-based data management application, continuous glucose monitoring, and supported blood glucose meters.

TNDM - TANDEM DIABETES CARE INC